ResMed RMD Masks and other — Net revenue by segment
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's masks and other — net revenue by segment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ResMed's masks and other — net revenue by segment?
- ResMed (RMD) reported masks and other — net revenue by segment of $1.05B in Q1 2026.
- How has ResMed's masks and other — net revenue by segment changed year-over-year?
- ResMed's masks and other — net revenue by segment increased by 15.5% year-over-year, from $908.74M to $1.05B.
- What does masks and other — net revenue by segment mean?
- This metric represents the total net revenue generated from the sale of patient interface masks, accessories, and related consumable components used in respiratory therapy. It serves as a critical indicator of the company's recurring revenue stream, as these products require frequent replacement by patients compared to the durable medical equipment used to deliver therapy. Growth in this segment reflects both the expansion of the installed base of therapy devices and the company's ability to maintain patient adherence and brand loyalty.